These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8519051

  • 1. Effectiveness of clinical pharmacist interventions in a hemodialysis unit.
    Tang I, Vrahnos D, Hatoum H, Lau A.
    Clin Ther; 1993; 15(2):459-64; discussion 432. PubMed ID: 8519051
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.
    Grabe DW, Low CL, Bailie GR, Eisele G.
    Clin Nephrol; 1997 Feb; 47(2):117-21. PubMed ID: 9049460
    [Abstract] [Full Text] [Related]

  • 3. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT, Witte KW, Hutchinson RA.
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [Abstract] [Full Text] [Related]

  • 4. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Horanieh BK.
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [Abstract] [Full Text] [Related]

  • 5. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
    Miyagawa CI, Rivera JO.
    Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
    [Abstract] [Full Text] [Related]

  • 6. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC, Sutton JD, Henderson GT.
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA, Armitstead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG.
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [Abstract] [Full Text] [Related]

  • 8. Documenting concurrent clinical pharmacy interventions.
    Haslett TM, Kay BG, Weissfellner H.
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [Abstract] [Full Text] [Related]

  • 9. An analysis of pharmacist interventions.
    Torchinsky A, Landry D.
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [Abstract] [Full Text] [Related]

  • 10. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R.
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [Abstract] [Full Text] [Related]

  • 11. [The clinical pharmacist in internal medicine--impact on the quality of therapeutic care].
    Hammerman A, Rotem R, Meidan N, Porath A.
    Harefuah; 1999 Jun 01; 136(11):862-4. PubMed ID: 10955131
    [Abstract] [Full Text] [Related]

  • 12. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit.
    Katona BG, Ayd PR, Walters JK, Caspi M, Finkelstein BW.
    Am J Hosp Pharm; 1989 Jun 01; 46(6):1179-82. PubMed ID: 2750769
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E, Livny S, Sterenberg A, Troitsa A, Oren M, Shani S.
    Harefuah; 2003 Jan 01; 142(1):5-9, 80. PubMed ID: 12647481
    [Abstract] [Full Text] [Related]

  • 14. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome.
    O'Dell KM, Kucukarslan SN.
    Ann Pharmacother; 2005 Sep 01; 39(9):1423-7. PubMed ID: 16046491
    [Abstract] [Full Text] [Related]

  • 15. Assessing whether a clinical pharmacy program is meeting its goals.
    Fink A, Kosecoff J, Oppenheimer PR, Smith WE, Brodie DC.
    Am J Hosp Pharm; 1982 May 01; 39(5):806-10. PubMed ID: 7081251
    [Abstract] [Full Text] [Related]

  • 16. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA.
    Arch Intern Med; 2003 Sep 22; 163(17):2014-8. PubMed ID: 14504113
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T, Marklund B.
    J Clin Pharm Ther; 2009 Jun 22; 34(3):319-27. PubMed ID: 19646078
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.